Announcements Trials
Browse Landscape Eligibility

Clinical Trials

276 trials
RecentStart dateEnrollment
FED × Clear all

Phase

Phase NA 127Phase 2 44Phase 1 18Phase 3 16Phase 4 14Phase 1/2 11Phase 2/3 8Phase EARLY_PHASE1 2

Status

Completed 162Recruiting 35Unknown 33Terminated 14Active not recruiting 11Not yet recruiting 10Withdrawn 9Enrolling by invitation 2

Sponsor Class

OTHER 81972INDUSTRY 26665NIH 5179NETWORK 2562OTHER_GOV 2412FED 276UNKNOWN 266INDIV 54

Study Type

Interventional 240Observational 36

Sponsor

Cancer Type

Gastrointestinal 83Genitourinary 67Thoracic 30Breast 17Lymphoid 13Gynecologic 10Other hematologic neoplasm 9Tumor-Agnostic 8Dermatologic 8Head & Neck 7CNS 4Plasma cell 3Other 3Sarcoma 1Myeloid 1Classical hematology 1

Conditions

Prostatic Neoplasms 53Colorectal Neoplasms 42Neoplasms 37Lung Neoplasms 22Breast Neoplasms 15Colonic Neoplasms 14Colonic Polyps 13Rare Diseases 9Carcinoma, Non-Small-Cell Lung 9Carcinoma, Hepatocellular 9Ovarian Neoplasms 7Adenoma 7Pulmonary Disease, Chronic Obstructive 6Neoplasm Metastasis 6Heart Failure 6Rectal Neoplasms 5Motor Activity 5Liver Neoplasms 5Head and Neck Neoplasms 5Fibrosis 5Carcinoma, Squamous Cell 5Barrett Esophagus 5Uterine Cervical Neoplasms 4Urinary Bladder Neoplasms 4Neoplasms by Site 4Mental Disorders 4Lymphoma 4Lung Diseases 4Leukemia 4Esophageal Neoplasms 4

Interventions

Exercise 6pembrolizumab 5enzalutamide 4Docetaxel 4Colonoscopy 4Celecoxib 4sargramostim 3apalutamide 3Prednisone 3Methods 3Leuprolide 3Itraconazole 3Imiquimod 3Granulocyte-Macrophage Colony-Stimulating Factor 3Cryotherapy 3Abiraterone Acetate 32-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 3abiraterone 2Yoga 2Topotecan 2Testosterone 2Tablets 2Simvastatin 2Radiosurgery 2Palliative Care 2Midazolam 2Golytely 2Gelatin 2Decision Support Techniques 2Collagenases 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements
NCT05842174 2026-04-16

TAQE

VA Office of Research and Development

Phase 1/2 Recruiting
93 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT06538636 2026-04-16

PASI

VA Office of Research and Development

Phase NA Not yet recruiting
23,520 enrolled
Thoracic

Lung Neoplasms

NCT04248582 2026-04-15

Cryotherapy for Locally Advanced Esophageal Cancer

Hunter Holmes Mcguire Veteran Affairs Medical Center

Phase 1 Active not recruiting
14 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT02606396 2026-04-14

Cryotherapy for Malignant Dysphagia in Patients With Advanced Esophageal Cancer

Hunter Holmes Mcguire Veteran Affairs Medical Center

Phase NA Completed
15 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus

NCT06610825 2026-04-13

CaRPET

Washington D.C. Veterans Affairs Medical Center

Phase 2 Recruiting
60 enrolled
Genitourinary

Prostatic Neoplasms

NCT04787744 2026-04-08

VA STARPORT

VA Office of Research and Development

Phase 2/3 Recruiting
464 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT04574518 2026-04-02

TeaMOUT

VA Office of Research and Development

Phase NA Active not recruiting
223 enrolled

Solitary Pulmonary Nodule, Smoking, Tobacco Use Cessation, Multiple Pulmonary Nodules, Tobacco Use

NCT06549036 2026-04-02

Veteran Peer Navigators to Promote Shared Decision Making for PSA Screening

VA Office of Research and Development

Phase NA Not yet recruiting
228 enrolled
Genitourinary

Prostatic Neoplasms

NCT05593497 2026-03-27

SNARE

VA Office of Research and Development

Phase 2 Recruiting
30 enrolled
Genitourinary

Prostatic Neoplasms

NCT06610474 2026-03-24

Evaluation of an Online Prostate Cancer Screening Decision Aid

Centers for Disease Control and Prevention

Phase NA Active not recruiting
510 enrolled
Genitourinary

Prostatic Neoplasms

NCT03445559 2026-03-17

A Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer Imaging

VA Office of Research and Development

Phase NA Active not recruiting
58 enrolled 15 charts
Genitourinary

Prostatic Neoplasms

NCT06963970 2026-03-13

PATH

VA Office of Research and Development

Phase NA Not yet recruiting
480 enrolled
Genitourinary

Dementia, Kidney Diseases, Lung Diseases, Obstructive, Neoplasms

NCT06681220 2026-03-11

Relapsed SCLC

VA Office of Research and Development

Phase 1/2 Recruiting
166 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT06275360 2026-03-02

RIVAL

VA Office of Research and Development

Phase 2 Recruiting
25 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04104893 2026-02-27

CHOMP

VA Office of Research and Development

Phase 2 Active not recruiting
40 enrolled
Genitourinary

Turcot syndrome, Prostatic Neoplasms

NCT06745258 2026-02-20

ICARE-LCS

VA Office of Research and Development

Not yet recruiting
7 enrolled
Thoracic

Lung Neoplasms

NCT02984761 2026-02-19

VALOR

VA Office of Research and Development

Phase NA Recruiting
670 enrolled
Thoracic

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT03621813 2026-02-18

Exercise Rehabilitation in Veteran Cancer Survivors

VA Office of Research and Development

Phase NA Active not recruiting
9 enrolled
Thoracic

Lung Neoplasms, Motor Activity, Neoplasms, Neuralgia

NCT04515004 2026-02-17

Leucoselect Phytosome for Neoadjuvant Treatment of Early Stage Lung Cancer

VA Office of Research and Development

Phase 2 Terminated
6 enrolled 3 charts
Thoracic

Early Stage Lung Cancer (I and II)

NCT07218367 2026-02-13

Phase I Trial of pH Resections of GBM at VA

VA Office of Research and Development

Phase 1 Not yet recruiting
12 enrolled
CNS

Glioblastoma, Glioma

NCT07408830 2026-02-13

VATSIT

VA Office of Research and Development

Phase NA Not yet recruiting
2,482 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT06061328 2026-02-04

OASIS

VA Office of Research and Development

Phase NA Enrolling by invitation
8,020 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Liver Neoplasms

NCT05796375 2026-01-30

ReplaceCysto

White River Junction Veterans Affairs Medical Center

Phase 2 Recruiting
240 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Neoplasms

NCT06646614 2026-01-28

Group Advanced Care Planning Pilot for Veterans

VA Palo Alto Health Care System

Phase NA Recruiting
50 enrolled
Tumor-Agnostic

Neoplasms

NCT05179408 2026-01-27

Targeted Telerehabilitation Following Curative Intent Therapy of Lung Cancer

VA Office of Research and Development

Phase NA Recruiting
40 enrolled
Thoracic

Lung Neoplasms

NCT05467748 2026-01-27

EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer

VA Office of Research and Development

Phase 1/2 Recruiting
66 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05212246 2026-01-22

B3C

VA Office of Research and Development

Phase 3 Not yet recruiting
1,630 enrolled
Dermatologic

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Patient Compliance, Keratosis, Actinic

NCT07351019 2026-01-20

Colonoscopy Bowel Prep Comparison Among Diabetic Patients

Eisenhower Army Medical Center

Phase 4 Recruiting
80 enrolled
Gastrointestinal

Colon Cancer Screening

NCT05926102 2026-01-13

ProGRESS

VA Office of Research and Development

Phase NA Recruiting
5,000 enrolled
Genitourinary

Genetic Risk Score, Prostatic Neoplasms

NCT03654053 2026-01-07

SACRED

VA Office of Research and Development

Phase 3 Active not recruiting
142 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

NCT04364256 2026-01-02

Muscle Stimulation for Physical Function During Stem Cell Transplant

VA Office of Research and Development

Phase NA Completed
46 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Multiple Myeloma, Muscular Atrophy, Hematologic Neoplasms

NCT06084338 2025-12-31

Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc

VA Office of Research and Development

Phase 2 Recruiting
60 enrolled
Genitourinary

Prostatic Neoplasms

NCT06778434 2025-12-22

The Effect of Topical Imipramine on Photodynamic Therapy-Mediated Immunosuppression on Forearms or Face on US Veterans

VA Office of Research and Development

Phase 2 Recruiting
48 enrolled
Dermatologic

Keratosis, Actinic

NCT01239082 2025-11-10

CONFIRM

VA Office of Research and Development

Phase NA Active not recruiting
50,126 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT06671613 2025-11-10

Stage IV NSCLC

VA Office of Research and Development

Phase NA Recruiting
66 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Fasting

NCT05563766 2025-11-05

A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer

VA Office of Research and Development

Phase 2 Recruiting
78 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma

NCT06574009 2025-11-03

Better Options for Chronic Cancer Pain

VA Office of Research and Development

Phase 4 Recruiting
294 enrolled

Opioid-Related Disorders, Chronic Pain

NCT05994482 2025-10-16

SOA

VA Office of Research and Development

Recruiting
130,000 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT05888623 2025-10-14

CADeNCE

VA Puget Sound Health Care System

Completed
334,200 enrolled
Gastrointestinal

Adenoma, Colorectal Neoplasms

NCT06520098 2025-10-14

Benefit VA

VA Office of Research and Development

Phase 2 Recruiting
100 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell

NCT06432985 2025-09-30

CM_TUD_Cancer

VA Office of Research and Development

Phase NA Recruiting
108 enrolled
Thoracic

Lung Neoplasms, Tobacco Use Disorder, Substance-Related Disorders

NCT05486572 2025-09-26

PREMIUM

VA Office of Research and Development

Phase NA Recruiting
4,700 enrolled
Gastrointestinal

Chronic Disease, Fibrosis, Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms

NCT05519241 2025-09-02

A Phase I Intravesical PPM Therapy for NMIBC

VA Office of Research and Development

Phase 1 Recruiting
29 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT04038502 2025-08-20

COBRA

VA Office of Research and Development

Phase 2 Recruiting
100 enrolled
Classical hematologyGenitourinary

Fanconi Anemia, Complementation Group N, Fanconi Anemia, Complementation Group D1, Hereditary Sensory and Autonomic Neuropathies, Prostatic Neoplasms

NCT00417001 2025-08-17

Reduction of Conscious Sedation Requirements by Olfactory Stimulation

United States Naval Medical Center, Portsmouth

Phase NA Withdrawn
Gastrointestinal

Colonic Polyps

NCT03298087 2025-08-01

Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer

VA Office of Research and Development

Phase 2 Completed
28 enrolled 10 charts
Genitourinary

Newly Diagnosed Oligometastatic Prostate Cancer

NCT06825715 2025-08-01

MIPO

VA Office of Research and Development

Phase NA Recruiting
2,653 enrolled
Genitourinary

Advanced Cancers of the Prostate

NCT07019844 2025-07-23

PSMA PET for the Staging and Management of Hepatocellular Carcinoma

VA Office of Research and Development

Recruiting
90 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT07071454 2025-07-23

PRECISE

VA Office of Research and Development

Phase NA Not yet recruiting
536 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT06389981 2025-07-18

VPC

VA Boston Healthcare System

Phase NA Completed
3 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡